甲氨蝶呤钠

  • 基本信息
  • 物化性质
  • 安全信息
  • 毒理性

甲氨蝶呤钠 基本信息

中文名称:
甲氨蝶呤钠 
中文别名:
甲氨蝶呤钠;
N-Chloroacetyl glycyl glycine;
N-Chloroacetylglycylglycine;
Pyridinium, 1-(3-sulfopropyl)-hydroxide, inner salt;
NDSB-201;
3-(1-Pyridino)-1-propanesulfonate;
PYRIDINIUM N-PROPYL SULFOBETAINE;
3-(1-PYRIDINIO)-1-PROPANESULFONATE INNER SALT;
3-(1-PYRIDINIO)PROPANESULFONATE;
3-(1-PYRIDINO)-1-PROPANE SULFONATE;
1-(3-SULFOPROPYL)PYRIDINIUM BETAIN;
1-(3-SULFOPROPYL)PYRIDINIUM BETAINE;
1-(3-SULFOPROPYL)PYRIDINIUM HYDROXIDE;
1-(3-SULFOPROPYL)PYRIDINIUM HYDRO 
英文名称:
L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, sodium salt(1:?)
英文别名:
Methotrexate sodium;
Einecs 239-495-5;
MTX sodium;
METHOTREXATE SODIUM FOR INJECTION 
CAS No.:
15475-56-6
分 子 式:
C20H22N8O5.xNa
分 子 量:
476.48
精确分子量:
476.15300
PSA:
213.37000
EINECS:
239-495-5
InChI:
InChI=1/C20H22N8O5.2Na/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30;;/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27);;/q;2*+1/p-2/t13-;;/m0../s1
安全术语:
Poison by intraperitoneal route. An experimental teratogen. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of Na2O and NOx. See also METHOTREXATE.
分子结构式:
SDS:
查看

甲氨蝶呤钠 物化性质

外观与性状:
橙色至黄色结晶粉末

甲氨蝶呤钠 安全信息

包装等级:
III
风险类别:
6.1(b)

甲氨蝶呤钠 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MA1240000
CHEMICAL NAME :
Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)b enzoyl)-, sodium salt
CAS REGISTRY NUMBER :
15475-56-6
LAST UPDATED :
199601
DATA ITEMS CITED :
12
MOLECULAR FORMULA :
C20-H21-N8-O5.Na
MOLECULAR WEIGHT :
476.48
WISWESSER LINE NOTATION :
T66 BN DN GN JNJ CZ EZ H1N1&R DVMYVQ2VO &-NA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
27 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
380 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Unreported
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
90 mg/kg/10D-I
TOXIC EFFECTS :
Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
DOSE :
200 ug/kg
SEX/DURATION :
female 9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
19200 ug/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - cytological changes (including somatic cell genetic material)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
19200 ug/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue) Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
19200 ug/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

MUTATION DATA

TYPE OF TEST :
Mutation test systems - not otherwise specified
TEST SYSTEM :
Rodent - mouse Lymphocyte
DOSE/DURATION :
1 umol/L
REFERENCE :
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year: 35,1427,1975 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X3245 No. of Facilities: 150 (estimated) No. of Industries: 1 No. of Occupations: 8 No. of Employees: 3943 (estimated) No. of Female Employees: 2465 (estimated)

推荐供应商更多供应商>>

湖北恩星生物科技有限公司

产品介绍:
产品名称:甲氨蝶呤钠 Cas号:15475-56-6 纯度: 包装信息:100kg,200kg,300kg,400kg,500kg 价格:64.0元 - 100.0元
联系方式:
联系人:邵经理 电话:16621771607 手机:16621771607
QQ: 2241752642
微信二维码
电话: 19906633110